Although our health is highly personal, the treatment and care we receive is often not. Medicines and care pathways have been designed based on evidence from large populations and, whilst clinicians do their best to tailor this to the needs of individuals, we still have a broad spectrum approach to treatment.
However, this is changing and, over the next decade or so, will completely change. Treatments will often be designed around the needs of specific individuals, tailored to the unique genetic characteristics of the patient. Decoding a person’s genome will be as standard as taking their blood pressure.
Advances in science and technology have the potential to transform services and outcomes in the NHS in the coming years, fundamentally changing the way we interact with clinicians, how data is used to inform decisions about our health, and how we understand, prevent, diagnose, treat and manage ill health.
This is a crucial time for the future of the NHS. In July 2018 the newly-appointed Secretary of State for Health and Social Care, Matt Hancock MP, made technology one of his three early priorities for the NHS under his leadership. Just a month earlier, the Prime Minister announced a new five-year funding settlement for the health service and asked the NHS to develop a long-term plan for its future. This presents a huge opportunity to realise the potential of new technologies to drive change and – ultimately
– renew the service’s focus on improving outcomes for patients.
“A new generation of technology has arrived that can be rapidly adopted, rapidly assessed, and rapidly iterated.” Matt Hancock MP, Secretary of State for Health and Social Care, speaking at NHS Expo 2018i
Roche employs more than 2,000 people in the UK, investing hundreds of millions of pounds in UK research and development each year. We want to start a conversation with the NHS and others in industry about what healthcare could be like in 2030, and the challenges that collectively we will need to overcome if we want to fully realise this opportunity. Based on our expertise in medicine development and diagnostics solutions – we have developed an outline of a vision for what future of healthcare in the NHS might look like.